Kailera Therapeutics, Inc. (KLRA)
NASDAQ: KLRA · Real-Time Price · USD
23.72
+0.21 (0.89%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Kailera Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Net Income | -148.96 | -329.57 |
| Depreciation & Amortization | 0.31 | 0.08 |
| Loss (Gain) From Sale of Investments | -1.73 | - |
| Stock-Based Compensation | 10.94 | 1.41 |
| Other Operating Activities | 2.44 | 139.5 |
| Change in Accounts Payable | 4.69 | 3.01 |
| Change in Other Net Operating Assets | 12.09 | 0.61 |
| Operating Cash Flow | -120.21 | -184.95 |
| Capital Expenditures | -2.09 | -0.39 |
| Investment in Securities | -490.51 | - |
| Investing Cash Flow | -492.6 | -0.39 |
| Long-Term Debt Issued | 100 | - |
| Net Debt Issued (Repaid) | 100 | - |
| Issuance of Common Stock | 0.1 | - |
| Other Financing Activities | -0.32 | - |
| Financing Cash Flow | 598.66 | 448.11 |
| Net Cash Flow | -14.15 | 262.77 |
| Free Cash Flow | -122.3 | -185.35 |
| Free Cash Flow Per Share | -6420.52 | - |
| Levered Free Cash Flow | -59.89 | - |
| Unlevered Free Cash Flow | -59.89 | - |
| Change in Working Capital | 16.78 | 3.62 |
Source: S&P Capital IQ. Standard template.
Financial Sources.